PCMarkers.com was started by leading prostate cancer experts and spearheaded by E. David Crawford, MD, to inform patients and physicians about non-invasive prostate cancer tests that have revolutionized the way prostate cancer is screened, analyzed and treated. By bringing attention to prostate cancer markers, PCM information, including this website, have led to fewer unnecessary prostate biopsies and more accurate and precise treatment.

 

 

Funding for PCMarkers is provided by the Jack A. Vickers Prostate Cancer Fund.

 

 

Meet our staff: a team of prostate cancer experts who have pioneered and championed the regular use of prostate cancer markers.

David Crawford, MD

E. David Crawford, MD, is a researcher and physician who has devoted his career to educating the medical profession and patients around the nation about men’s health issues and finding effective techniques and procedures to address prostate cancer, the most common malignancy affecting men in the United States.

He is currently a Professor of Urology at the University of California San Diego. He is also emeritus distinguished endowed Professor of Surgery, Urology and Radiation Oncology and Head of the Section of Urologic Oncology at the University of Colorado.

Dr. Crawford has authored or coauthored more than 810 scientific articles, published 7 textbooks, authored more than 60 book chapters and provided more than 2,200 educational talks for patients and physicians. Dr. Crawford served on the board of governors and the scientific advisory board of the Southwest Oncology Group. He was chairman of the Genitourinary Cancer Committee, which is the largest clinical trials group in the world, for 27 years.

Crawford’s’ involvement in the national prostate cancer arena has been widely recognized. He has received many honors and awards, including the CAP Cure Annual Award for Scientific Presentation in 1999. In 1997, he was presented with a “Freddie Award” at the AMA International Health and Medical Film Competition for the program, ITV: The Cutting Edge Medical Report (Prostate Cancer: Understanding, Diagnosing, and Defeating), which Crawford hosted with special guest, retired General Norman Schwarzkopf. Crawford again won a prestigious “Freddie Award”. He is a member of Best Doctors of America and was named Healthcare Provider of the Year in the Denver Metro area by the Denver Business Journal. Read More

Paula Robins

Paula Robins is Patient Navigator for the Department of Urology at the University of California San Diego offering comprehensive, dedicated care to assist patients, families and caregivers through all phases of their cancer journey.

The navigation program facilitates patient orientation to available services, connecting to the correct caregivers, answering questions, coordinating multiple medical appointments and providing emotional support.

Prior to  UCSD, Paula was a Patient Navigator with Genesis Healthcare Partners assisting patients through their biopsy, diagnosis and treatment journey.

Paula worked as Director of Operations for Stratify Genomics and the PromptPGS genetic test that helped assess an individuals’ risk for prostate cancer.

Paul Arangua, B.S.

Paul is a study coordinator at the University of Colorado and has been part of numerous studies including The Application of Targeted Focal Cryotherapy for the Treatment of Organ Confined Prostate Cancer, The Injection of Botulinum Toxin for the Treatment of Benign Prostatic Hyperplasia, Salvage Cryotherapy Online Registry Evaluation, and several other investigator initiated studies. Currently, Paul works closely on several self-designed, investigator initiated quality of life studies on various prostate and testicular cancer patient cohorts. He has extensive experience using REDCap to design databases and automated-distribution survey instruments. Recently, he has designed an iPad compliant quality of life survey for all 3D prostate cancer biopsy patients. Paul has extensive experience with the ProView software platform, which he uses to perform real-time 3D reconstruction in patients during 3D prostate cancer biopsy. His special interests include database design and data analysis, study design, clinical epidemiology, and minimally invasive prostate cancer diagnostic and treatment procedures including 3D prostate cancer biopsy and Targeted Focal Cryotherapy.